XPRESSPA GROUP INC (XSPA) Fundamental Analysis & Valuation

NASDAQ:XSPA • US98420U7037

Current stock price

0.655 USD
-0.04 (-5.65%)
At close:
0.6501 USD
0 (-0.75%)
After Hours:

This XSPA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. XSPA Profitability Analysis

1.1 Basic Checks

  • XSPA had negative earnings in the past year.
  • In the past year XSPA had a positive cash flow from operations.
XSPA Yearly Net Income VS EBIT VS OCF VS FCFXSPA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 -20M -40M -60M -80M

1.2 Ratios

Industry RankSector Rank
ROA -3.28%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XSPA Yearly ROA, ROE, ROICXSPA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 200 -200 -400

1.3 Margins

Industry RankSector Rank
OM -0.24%
PM (TTM) -3.55%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XSPA Yearly Profit, Operating, Gross MarginsXSPA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. XSPA Health Analysis

2.1 Basic Checks

  • XSPA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • XSPA has more shares outstanding than it did 1 year ago.
  • XSPA has a better debt/assets ratio than last year.
XSPA Yearly Shares OutstandingXSPA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
XSPA Yearly Total Debt VS Total AssetsXSPA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -2.74, we must say that XSPA is in the distress zone and has some risk of bankruptcy.
  • There is no outstanding debt for XSPA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.74
ROIC/WACCN/A
WACC8.27%
XSPA Yearly LT Debt VS Equity VS FCFXSPA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • XSPA has a Current Ratio of 5.93. This indicates that XSPA is financially healthy and has no problem in meeting its short term obligations.
  • A Quick Ratio of 5.84 indicates that XSPA has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 5.93
Quick Ratio 5.84
XSPA Yearly Current Assets VS Current LiabilitesXSPA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. XSPA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 88.67% over the past year.
  • XSPA shows a strong growth in Revenue. In the last year, the Revenue has grown by 417.44%.
  • The Revenue has been growing by 43.80% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)88.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)417.44%
Revenue growth 3Y13.75%
Revenue growth 5Y43.8%
Sales Q2Q%49.55%

3.2 Future

  • XSPA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.45% yearly.
  • The Revenue is expected to grow by 0.23% on average over the next years.
EPS Next Y-814%
EPS Next 2Y-172.76%
EPS Next 3Y-11.28%
EPS Next 5Y10.45%
Revenue Next Year-2.07%
Revenue Next 2Y0.7%
Revenue Next 3Y0.05%
Revenue Next 5Y0.23%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XSPA Yearly Revenue VS EstimatesXSPA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
XSPA Yearly EPS VS EstimatesXSPA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2020 2021 2022 2023 2024 2025 0 -10 -20 -30 -40 -50

More info and screens

Find the best growth stocksShow best growing peers

0

4. XSPA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for XSPA. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XSPA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XSPA Price Earnings VS Forward Price EarningsXSPA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2.35
XSPA Per share dataXSPA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

  • XSPA's earnings are expected to decrease with -11.28% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-172.76%
EPS Next 3Y-11.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XSPA Dividend Analysis

5.1 Amount

  • XSPA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

XSPA Fundamentals: All Metrics, Ratios and Statistics

XPRESSPA GROUP INC

NASDAQ:XSPA (10/24/2022, 8:00:02 PM)

After market: 0.6501 0 (-0.75%)

0.655

-0.04 (-5.65%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)08-15
Earnings (Next)11-14
Inst Owners0%
Inst Owner Change0%
Ins Owners1.84%
Ins Owner Change0%
Market Cap61.58M
Revenue(TTM)93.77M
Net Income(TTM)-3.33M
Analysts82.86
Price Target2.04 (211.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.1%
Min EPS beat(2)21.57%
Max EPS beat(2)34.64%
EPS beat(4)3
Avg EPS beat(4)56.94%
Min EPS beat(4)-50.98%
Max EPS beat(4)222.55%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)10.34%
Min Revenue beat(2)-0.7%
Max Revenue beat(2)21.38%
Revenue beat(4)3
Avg Revenue beat(4)47.5%
Min Revenue beat(4)-0.7%
Max Revenue beat(4)163.26%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.66
P/FCF N/A
P/OCF 7.94
P/B 0.86
P/tB 0.99
EV/EBITDA -2.35
EPS(TTM)-0.04
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.08
OCFY12.6%
SpS1
BVpS0.76
TBVpS0.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.28%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -0.24%
PM (TTM) -3.55%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 330.54%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.93
Quick Ratio 5.84
Altman-Z -2.74
F-Score8
WACC8.27%
ROIC/WACCN/A
Cap/Depr(3y)119.29%
Cap/Depr(5y)89.95%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-814%
EPS Next 2Y-172.76%
EPS Next 3Y-11.28%
EPS Next 5Y10.45%
Revenue 1Y (TTM)417.44%
Revenue growth 3Y13.75%
Revenue growth 5Y43.8%
Sales Q2Q%49.55%
Revenue Next Year-2.07%
Revenue Next 2Y0.7%
Revenue Next 3Y0.05%
Revenue Next 5Y0.23%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y164.29%
OCF growth 3YN/A
OCF growth 5YN/A

XPRESSPA GROUP INC / XSPA Fundamental Analysis FAQ

What is the fundamental rating for XSPA stock?

ChartMill assigns a fundamental rating of 5 / 10 to XSPA.


Can you provide the valuation status for XPRESSPA GROUP INC?

ChartMill assigns a valuation rating of 2 / 10 to XPRESSPA GROUP INC (XSPA). This can be considered as Overvalued.


Can you provide the profitability details for XPRESSPA GROUP INC?

XPRESSPA GROUP INC (XSPA) has a profitability rating of 5 / 10.


What is the financial health of XPRESSPA GROUP INC (XSPA) stock?

The financial health rating of XPRESSPA GROUP INC (XSPA) is 6 / 10.